Philippe Rogueda

Chief Business Officer, Quality Director
Merxin Ltd.
Mehrdad Kheiripour
Co-founder and CBO of Merxin Ltd, Philippe is a Fellow of the Royal Society of Chemistry and OINDP expert with an accomplished track record delivering technology and global projects across R&D and commercial industrialization. Philippe has held a number of positions in the Inhaled Drug Delivery space, starting as a formulation scientist in the pMDI formulation labs of AstraZeneca; as a principal scientist at Novartis designing DPI, nasal and nebulisers inhaled therapies; as an Executive Director of Inhaled Products R&D at Actavis/TEVA; before setting up Merxin Ltd to make inhaler technology accessible to a wider audience. Philippe is principal consultant at Aedestra Ltd (Hong Kong), founder of Inhalation Asia Ltd (Hong Kong) and of Anthocan Ltd (UK) a company dedicated to the formulating of inhaled cannabis therapies.


No data was found